Porcilis Ery + Parvo-Hyperdrug

Presentation An inactivated vaccine containing at least 1 ppd Erysipelothrix rhusiopathiae antigen, strain M2 (serotype 2) and Porcine parvovirus (PPV) strain 014 inducing at least 7.4 log2 HI units per dose in an aqueous adjuvant. The vaccine contains 0.05% formaldehyde as a preservative and 150 mg dl-a tocopherol per dose. Uses For the active immunisation of sows and gilts as an aid in the control of swine erysipelas and for the protection of embryos and foetuses against porcine parvovirus infection. Dosage and administration The dose is 2 ml per pig, given by deep intramuscular injection behind the ear. Ensure that vaccination equipment is clean and sterile before use. Vaccination programme Gilts should be vaccinated against E. rhusiopathiae and PPV before first mating. A single injection, not less than 2 weeks before mating is sufficient to protect the following pregnancy from damage due to PPV. For the induction of protection against erysipelas, an initial course of two vaccinations is recommended. This can be achieved with the single component erysipelas vaccine given either 4 weeks before, or 4 weeks after the administration of Porcilis Ery+Parvo. Sows should be revaccinated against erysipelas during each lactation period (i.e. at no more than 6 month intervals) and against parvovirus annually. Contra-indications, warnings, etc Do not vaccinate unhealthy animals. Do not mix with other vaccines or substances. Other vaccines should not be administered within 14 days before or after vaccination with Porcilis Ery+Parvo. Vaccination reactions normally consist of a slight (0.5°C), transient (normal within 24 hours) rise in body temperature. A mild local swelling (less than 5 cm in diameter, normal within 3 days) and some reluctance to move may be seen in a very small proportion (<5%) of vaccinated animals. Stress should be avoided when vaccinating animals, particularly during later stages of pregnancy. Withdrawal period Zero days. For animal treatment only. Keep out of reach and sight of children. Pharmaceutical precautions Store between +2° and +8°C. Protect from light. Do not freeze. Allow to reach ambient temperature (15°–25°C) before use. Shake well before and during use. Once opened, use entire contents within 10 hours. Disposal Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant, in accordance with the national requirements.

Dosage and administration The dose is 2 ml per pig, given by deep intramuscular injection behind the ear. Ensure that vaccination equipment is clean and sterile before use. Vaccination programme Gilts should be vaccinated against E. rhusiopathiae and PPV before first mating. A single injection, not less than 2 weeks before mating is sufficient to protect the following pregnancy from damage due to PPV. For the induction of protection against erysipelas, an initial course of two vaccinations is recommended. This can be achieved with the single component erysipelas vaccine given either 4 weeks before, or 4 weeks after the administration of Porcilis Ery+Parvo. Sows should be revaccinated against erysipelas during each lactation period (i.e. at no more than 6 month intervals) and against parvovirus annually.

Contra-indications, warnings, etc Do not vaccinate unhealthy animals. Do not mix with other vaccines or substances. Other vaccines should not be administered within 14 days before or after vaccination with Porcilis Ery+Parvo. Vaccination reactions normally consist of a slight (0.5°C), transient (normal within 24 hours) rise in body temperature. A mild local swelling (less than 5 cm in diameter, normal within 3 days) and some reluctance to move may be seen in a very small proportion (<5%) of vaccinated animals. Stress should be avoided when vaccinating animals, particularly during later stages of pregnancy. Withdrawal period Zero days. For animal treatment only. Keep out of reach and sight of children. Pharmaceutical precautions Store between +2° and +8°C. Protect from light. Do not freeze. Allow to reach ambient temperature (15°–25°C) before use. Shake well before and during use. Once opened, use entire contents within 10 hours. Disposal Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant, in accordance with the national requirements.

Legal category POM-V Packaging Quantities Multidose vials containing 10, 25, 50 or 125 doses. Further information Porcine parvovirus (PPV) is not the only cause of reproductive failure in pigs. A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system. Immunogenicity of the vaccine will be reduced by poor storage or inappropriate administration. Immunocompetence of the animal may be compromised by a variety of factors including poor health, nutritional status, genetic factors, concurrent drug therapy and stress. Marketing authorisation number Vm 01708/4334.